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LIST OF ABBREVIATIONS 
 
AIS   androgen insensitivity syndrome 
AR   androgen receptor 
AVP   arginine vasopressin 
AVP-ir  arginine vasopressin immunoreactive 
BST   bed nucleus of the stria terminalis 
DHT   dihydrotestosterone 
E2   estradiol 
ER   estrogen receptor 
LS   lateral septum 
MeA   medial amygdaloid nucleus 
MPOA  medial preoptic area 
PVN   paraventricular nucleus 
SON   supraoptic nucleus 
T   testosterone 
Tfm   testicular feminilization mutation 
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ABSTRACT 
In rodents as well as in many other mammalian and non-mammalian species, the 
arginine-vasopressin (AVP) system includes a parvocellular sexually dimorphic 
portion located within the bed nucleus of the stria terminalis (BST), the medial 
amygdaloid nucleus (MeA) and the lateral septum. In this system, males have more 
cells and denser projections than females, neurons show androgen and estrogen 
receptors, and gonadal hormones are required for the activation. However, the role of 
these hormones for the differentiation of the system is not clear. Previous studies 
performed on aromatase knock out mice suggested that estradiol is not necessary for 
the differentiation of the system, but it is important for its activation in adulthood. 
To elucidate the role of androgens on differentiation and functioning of AVP 
parvocellular system, we compared male and female rats with a non-functional 
mutation of androgen receptor (Tfm, testicular feminization mutation) to their control 
littermates. Our data show that the lack of a functional androgen receptor significantly 
decreases the expression of AVP immunoreactivity within the BST and MeA of male 
Tfm. Thus supporting the hypothesis that androgens, through the action of their 
receptor, should have a relevant role in the organization and modulation of the AVP 
parvocellular sexually dimorphic system. 
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INTRODUCTION 
 
Gonadal steroids, through their interaction with intracellular receptors, induce several 
effects in target cells; these receptors are members of ligand-activated transcription 
factors family that bind responsive elements located on the genome and therefore are 
able to modulate the transcription of a wide variety of genes (McCarthy, 2008). 
Specific nuclear receptors for estrogens and androgens are present in the developing 
brain of rodents (DonCarlos and Handa, 1994, DonCarlos, 1996, McAbee and 
DonCarlos, 1998). Therefore, gonadal steroids are likely to play a crucial role in brain 
plasticity and development; in particular, they may induce the differentiation of 
sexually dimorphic structures and behaviors (Panzica et al., 1995, McCarthy and 
Konkle, 2005, McCarthy and Arnold, 2011, Lenz et al., 2012).  
Sex difference in testosterone (T) levels during development has been recognized as 
the driving force of sexual differentiation of the mammalian central nervous system. 
In male rats, T secretion reaches the peak from prenatal days 18-20 (Perakis and 
Stylianopoulou, 1986). This early elevation in T levels coincides with the period 
(critical perinatal period) when T can permanently influence the development of 
behavior and neural structures (Cooke et al., 1998). Within the brain, T is metabolized 
into estradiol (E2) by aromatase or into 5-dihydrotestosterone (5-DHT) by 5-
reductase. These two steroids may bind their receptors inducing the differentiation of 
neural circuits. In some cases both androgen (AR) and estrogen receptors (ER) may 
contribute to structural plasticity of nervous circuits, as for the posterior part of the 
amygdala (MeP) (Cooke et al., 2003).  
The AR mediates age- and tissue-specific actions of androgens and is responsible for 
the development, maintenance and regulation of the male reproductive system 
(Raskin et al., 2009, Juntti et al., 2010). AR is encoded by a X-linked gene, which 
consists of 8 exons, and it is essential for androgenic action, of both T and 5-DHT 
(Gobinet et al., 2002).  
In humans, mutations of the AR gene represent the molecular basis of androgen 
insensivity syndrome (AIS), a rare X-linked disorder characterized by a defective 
virilization in genetic males ranging from partial forms, in which 46, XY phenotypic 
males are infertile, to the complete syndrome showing a female phenotype 
(Brinkmann, 2001, McPhaul, 2002, Hughes et al., 2012)  
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In mammals, as well as in most vertebrates, part of the arginine-vasopressin (AVP) 
neuronal system is sexually dimorphic and gonadal steroids sensitive in adulthood 
(for a review see De Vries and Panzica, 2006). The bed nucleus of the stria terminalis 
(BST) and the amygdala contain more AVP-immunoreactive (AVP-ir) cells in male 
than in female and projections from these nuclei to the lateral septum (LS) are denser 
in male than in female; in addition, several other brain regions show sexually 
dimorphic AVP innervation (De Vries et al., 1984b, Rood et al., 2013).  
Histological investigations demonstrated several sexually dimorphic features (volume, 
cell number and cell size) in BST and amygdala. The BST shows a consistent pattern 
of sex differences in several mammalian species [guinea pig (Hines et al., 1992); rat 
(Del Abril et al., 1987); rabbit (Segovia et al., 2006)] and even in humans (Zhou et al., 
1995). Both nuclei have a crucial role in the regulation of rodent male and female 
sexual and aggressive behaviors (Veening and Coolen, 1998, Veening et al., 2005). In 
particular, the rodent parvocellular AVP system is involved in the control of social 
behaviors, such as pair bonding, social recognition, aggressivity, depression and 
anxiety (see Compaan et al., 1993, Veenema and Neumann, 2008, Choleris et al., 
2009, Rotzinger et al., 2010).  
Several studies have investigated the development of sexually dimorphic AVP system 
in mammals and other vertebrates and the role played by gonadal hormones for its 
regulation (see for a review De Vries and Panzica, 2006).  
Gonadectomy and early T replacement therapy affect the organization of limbic AVP 
system and AR expression, suggesting that both T and AR are involved in the 
differentiation of this system (Bingham and Viau, 2008). Also aromatase (the enzyme 
converting T into E2) expression is reduced by gonadectomy and restored by T 
replacement (Roselli et al., 1987). However, whereas the lack of a functional 
aromatase gene (ArKO) induces an apparent reduction of AVP cell number and fiber 
innervation in BST, amygdala and LS (Plumari et al., 2002), adult administration of 
E2 in the same mice induced a full recovery of male AVP system (Pierman et al., 
2008). Therefore, it seems that E2 is not necessary for the differentiation of the 
sexually dimorphic AVP system, while it plays a major role in adulthood to stimulate 
the same system. 
The Tfm rats (characterized by a testicular feminilization due to a spontaneous 
mutation of the AR gene) may help in elucidate the role of androgens and ARs in the 
activation/organization of the sexually dimorphic AVP system. These animals show a 
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low level of the aromatase protein itself, even in T-treated gonadectomized Tfm male 
rats (Roselli et al., 1987). In addition, Tfm rodents show alterations in some behaviors 
[i.e. adult playful attack and defense (Field et al., 2006), anabolic androgenic steroid-
induced aggressive behavior (Wu et al., 2009, Robinson et al., 2012), anxiety-related 
behaviors (Zuloaga et al., 2008, Zuloaga et al., 2011) or social investigation (Tejada 
and Rissman, 2012)] that are partially dependent by the AVP system (Veenema and 
Neumann, 2008, Veenema et al., 2010). Also, some neuronal circuits are altered in 
these animals, as the nitric oxide producing system of BST and other hypothalamic 
nuclei (Martini et al., 2008).  
As Tfm rodents have decreased AR binding but apparently normal ER binding 
(Attardi et al., 1976), these animals offer a way to examine the contribution of the AR 
to the sexual differentiation of rodent brain in gonadally intact individuals.  
 
 
MATERIALS AND METHODS 
 
Animals 
Female Tfm rats from the colony of the Department of Psychobiology of UNED, 
Madrid, Spain, (for the origin of the strain see Garcia-Falgueras et al., 2005) were 
analyzed and identified by polymerase chain reaction (PCR, Fernandez et al., 2003) as 
females heterozygous for the Tfm mutation (X
Tfm
/X). These rats were mated with 
Wistar male rats (Charles River; Criffa, Barcelona) to obtain the animals used in this 
experiment (N = 20). The animals obtained in the matings have the same genetic 
background (X
Tfm
/X x Wistar male, X/Y) and therefore are comparable to each other. 
The experimental groups, classified after PCR analyses, were as follows: (a) Tfm 
males (X
Tfm
/Y, N = 5); (b) Tfm carrier females (X
Tfm
/X, N = 5); (c) control littermate 
males (X/Y, N = 5), and (d) control littermate females (X/X, N = 5). 
At the age of 21 days, the animals were housed in monosexual groups in standard 
cages and maintained in 12:12 light/dark cycle (lights off at 8:00 PM). Food and 
water were provided ad libitum. The animal room was kept at 22 ± 2 °C. Animal care 
and handling throughout the experimental procedures were in accordance with the 
European Union Council Directive of 24 November 1986 (86/609/EEC) and the 
experiment was approved by the ethical committee of the UNED. The genotyping of 
the animals was performed at the Department of Pharmacological and Biomedical 
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Sciences (Milano, Italy) by using 200 µl of peripheral blood according to the protocol 
previously developed (Fernandez et al., 2003, Garcia-Falgueras et al., 2005). 
 
Colchicine injection and sacrifice 
At the age of 60 days, all the animals were subjected to an intracerebroventricular 
injection of colchicine to increase the AVP immunostaining (Compaan et al., 1993, 
Plumari et al., 2002, Pierman et al., 2008). Females were inspected for the stage of the 
cycle (examination of vaginal smears) and injected only in estrus. Briefly, the animals 
were deeply anaesthetized with a mixture of ketamine (80mg/Kg of body weight), 
valium (10mg/Kg of body weight), and atropine (0,05mg/Kg of body weight) and 
positioned in a stereotaxic apparatus (Kopf, Tujunga, CA, USA). They were then 
stereotaxically injected into the left lateral ventricle with 10l of solution 
corresponding to 250g/Kg of body weight of colchicine dissolved in distillated 
water. Accuracy of the position of the injection cannula was controlled by observing 
the increase in pressure in the cannula when it entered the ventricle. Later inspection 
of brain sections revealed no trace of damaged tissue around the lateral ventricle 
except for the penetration path of the needle. 48 hours after the colchicine injection, 
rats were deeply anesthetized with the same anesthetic mixture (ketamine-valium-
atropine) and perfused through the heart with saline solution (0.9%) until vessels were 
completely blood-free, and then with fixative (4% paraformaldehyde in 0,1 M 
phosphate buffer, pH 7,3). Brains were dissected out of the skull, post-fixed for 2 
hours in the same fixative and rinsed in 0.01 M phosphate buffer saline (PBS). They 
were then placed overnight in a 30% sucrose solution in PBS, frozen in precooled 
liquid isopentane at -35°C, and stored in a deep freezer at –80°C until sectioning. 
 
Immunohistochemistry 
Brains were serially cut in the coronal plane at 25 µm thickness using a cryostat and 
collected in a cryoprotectant solution (Watson et al., 1986) at -20°C. Every forth 
section one was stained for AVP by immunohistochemistry using the free floating 
technique. Sections were immunostained using a commercial AVP antibody (ICN 
Pharmaceuticals, CA; USA) diluted 1:20,000. The same antibody has been previously 
used to stain the AVP cells and fibers in rodents species (Ferris et al., 1995, Villalba 
et al., 1999, Plumari et al., 2002, Pierman et al., 2008). The specificity of this 
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 8 
antibody to vasopressin (and the absence of any cross-reactivity with oxytocin) has 
been validated previously (Ferris et al., 1995). In the present study, we have 
performed the following controls: a) the primary antibody was omitted or replaced 
with an equivalent concentration of normal serum (negative controls); b) the 
secondary antibody was omitted. In these conditions, cells and fibers were totally 
unstained. 
Briefly, the free-floating sections collected in the cryoprotectant solution were washed 
overnight in PBS at pH 7.3. The following day, sections were first washed in PBS 
containing 0.2 % Triton X-100 for 30 min and then treated to inhibit endogenous 
peroxidase activity with a solution of PBS containing methanol/hydrogen peroxide for 
20 min (Streefkerk, 1972). Sections were incubated for 30 min with normal goat 
serum (Vector Laboratories, Burlingame, CA, USA) and incubated overnight at room 
temperature with anti-AVP antibody diluted 1:20,000 in PBS, pH 7.3-7.4, containing 
0.2% Triton X-100. A biotinilated goat anti-rabbit secondary antibody (Vector 
Laboratories, Burlingame, CA, USA) was then employed at a dilution of 1:200 for 60 
min at room temperature. The antigen-antibody reaction was revealed by 60 min 
incubation with avidin-peroxidase complex (Vectastain ABC Kit Elite, Vector 
Laboratories, Burlingame, CA, USA). The peroxidase activity was visualized with a 
solution containing 0.400 mg/ml 3,3-diamino-benzidine (Sigma, Milan, Italy) and 
0.004% hydrogen peroxide in 0.05M Tris-HCl buffer pH 7.6. Sections were mounted 
on chromallum coated slides, air dried, cleared in xylene and cover slipped with 
Entellan (Merck, Milan, Italy). Sections were collected on chromalum-coated slides, 
air-dried, washed in xylene, and cover slipped with Entellan (Merck, Milano, Italy).  
An alternate set of sections was stained with toluidine blue to set up a series of Nissl-
stained section that were used for anatomical orientation. Identification of all 
structures was based on the rat brain atlas of Paxinos and Watson (1998). 
 
Quantitative analysis 
For quantitative analysis, all slides were first coded so that the observer was blind to 
the experimental treatments. Sections were chosen to match similar levels of the 
regions to be investigated. Selected fields were acquired through a Zeiss Axioplan I 
microscope equipped with a Leica DFC 320 digital telecamera connected to an Apple 
G4 Macintosh. Digital images were later analyzed with Image J program (version 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 9 
1.46, a public domain program written by W. Rasband at the U.S. National Institutes 
of Health, Bethesda, MD, USA). 
 
The cells count and the fractional area, covered by AVP-ir structures, were evaluated 
according to the following protocols in the regions schematically reported in Fig. 1: 
- in the BST and amygdala we counted the number of AVP-ir cells (identified for the 
presence of a clearly labeled cell body) using the cell counter plug-in of ImageJ. We 
counted all the positive neurons within a rectangle of fixed size (500,000 µm
2
) placed 
over the nuclei (Fig. 1). The measures were performed in two separate rostro-caudal 
levels of the bed nucleus of the stria terminalis (BST: -0.40 and -0.80 relative to 
Bregma, (Paxinos and Watson, 1998), and medial amygdaloid nucleus (MeA: -2.12 
and –2.56 relative to Bregma, (Paxinos and Watson, 1998) to control for a possible 
heterogeneity of AVP distribution in these structures.  
 
- In the LS, as well as in the BST and amygdala, we measured the density of AVP-ir 
structures by calculating, in binary transformations of the images (threshold function 
of Image J), the fractional area (percentages of pixels) covered by positive structures 
in predetermined regions with a fixed extension (500,000 µm
2
) as described in our 
previous studies in mice and quails (Viglietti-Panzica et al., 2001, Plumari et al., 
2002, Viglietti-Panzica et al., 2007, Pierman et al., 2008). In particular we considered 
for BST, and MeA the same levels described above and for LS two additional rostro-
caudal levels (coordinates 0.48 and -0.26 relative to Bregma in the rat brain atlas, see 
Fig. 1). 
 
Statistical analysis 
Statistical analyses were performed using the software Statview 5.0 (Abacus 
Concepts, Berkely, CA, USA). 
The average from 2 coronal sections was used for data analysis, since a preliminary 
analyses revealed no significant difference between the anterior-posterior levels for 
each considered nucleus (BST, MeA, and LS). We have therefore performed a two-
way analysis of variance (ANOVA, genotype and sex as independent factors) on the 
average cells count (BST and MeA) or on the average fractional area value (BST, 
MeA, and LS). When appropriate, we applied a post-hoc comparison test (Fisher 
PLSD). Differences were considered statistically significant for p≤0.05 .  
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RESULTS 
 
The qualitative observation of the immunostained sections obtained from colchicine-
injected WT male rats (XY) showed a distribution of AVP-ir structures in line with 
what has been previously described in rodents (De Vries et al., 1985, Plumari et al., 
2002, Grassi et al., 2010, Rood and De Vries, 2011). In particular, we observed a 
dense population of AVP-ir parvocellular neurons and fibers in the BST (Fig.2), and 
the MeA (Fig.3), whereas the presence of positive fibers within the LS (Fig.4) was 
rather weak. The comparison with WT females evidenced an obvious sex difference 
(females have less immunoreactivity than males) for BST, MeA, and LS.  
When comparing AVP immunostained sections of XY and Tfm (X
tfm
/Y) male rats we 
observed a sharp decrease of AVP-ir elements in the BST and in the MeA of Tfm 
males (Figs.2-3). A slight decrease of the vasopressinergic innervation was detectable 
in the LS (Fig.4). These qualitative observations were confirmed by quantitative 
analysis of AVP immunoreactivity, whose results are summarized in Fig.5.  
Regarding the average fractional area value, for BST, and MeA the two-way ANOVA 
reported significant effects for all the considered parameters (sex, genotype, and 
interaction sex-genotype). For the BST: sex (F1,1=32.76, p<0.0001), genotype 
(F1,1=15.03, p=0.001), interaction between sex and genotype (F1,1,1=10.32, p=0.005). 
For the MeA: sex (F1,1=17.88, p=0.0006), genotype (F1,1=9.61, p=0.007), interaction 
between sex and genotype (F1,1,1=8.70, p=0.009). The post-hoc Fisher PLSD test 
reported highly significant differences (p<0.0001 for BST, and p<0.001 for MeA) 
between male XY and male X
tfm
Y, male XY and female XX, and male XY and 
female X
tfm
X.  
For the LS, the two-way ANOVA reported a significant effect only for sex (F1,1= 
10.32, p=0.003). The post-hoc Fisher PLSD test reported significant differences 
(p=0.01) for comparisons of male XY against female XX or female X
tfm
X.  
For the average cell counts value in the BST and MeA the two-way ANOVA reported 
significant effects for the considered parameters (sex, genotype, and interaction sex-
genotype). For the BST: sex (F1,1=161.63, p<0.0001), genotype (F1,1=19.34, 
p=0.0004), interaction between sex and genotype (F1,1,1=17.00, p=0.0008). For the 
MeA: sex (F1,1=6.40, p=0.0223), genotype (F1,1=4.83, p=0.0430), interaction between 
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sex and genotype (F1,1,1=4.547, p=0.0488). The post-hoc Fisher PLSD test reported 
highly significant differences (p<0.0001 for BST, and p<0.01 for MeA) between male 
XY and male X
tfm
Y, male XY and female XX, and male XY and female X
tfm
X. 
 
DISCUSSION 
 
Present results confirm the existence of significant sexual differences in the 
parvocellular part of the AVP system of rat brain (De Vries and Panzica, 2006). In 
particular, we found the presence of highly significant differences in the density of 
AVP-ir elements (higher in males than in females) in BST, MeA, and LS nuclei. In 
addition, we show that the absence of a fully functional AR, causing the testicular 
feminization syndrome, induces significant decrease of the expression of AVP in 
these nuclei. This decrease is so marked that in Tfm rats the sex dimorphism of AVP 
is no longer observed. In fact, male X
tfm
Y shows a significant decrease of AVP-ir in 
the BST, and the MeA nuclei in comparison to male XY, whereas the observed 
decrease of the immunoreactivity in the LS is not significant. The lack of significant 
effect of AR mutation on the AVP innervation of LS is intriguing, because these 
fibers derive from the BST/medial amygdala system (De Vries and Buijs, 1983, Caffé 
et al., 1987). However, the presence of a decrease not reaching the significance could 
be due to the large variation of experimental measurements (see the extent of standard 
error in the bar graphs), as well as to the use of colchicine injection to increase the 
immunoreactivity in cell bodies of BST and MeA. This treatment is, in fact, 
interfering with the axonal flux (Brat and Brimijoin, 1992) and we observed an 
overall decrease of the AVP immunoreactivity in extra-hypothalamic fibers’ systems 
of our animals. 
The masculinization of the rodent hypothalamus (i.e. volume of the structure, number 
of neurons, expression of neurotransmitters, and neuropeptides) is widely assumed to 
be due to estrogenic metabolites of testosterone interacting with ERs during perinatal 
critical period (aromatization hypothesis), while the -fetoprotein (AFP) protects the 
developing female brain from masculinization and defeminization by estrogens (for a 
review see McCarthy et al., 2009). However, this is not the only mechanisms present 
in the vertebrate brain, for example, in the avian hypothalamus estradiol has exactly 
the opposite effect, inducing the demasculinization of those avian behaviors and 
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circuits that are sexually differentiated (for a review see Balthazart and Adkins-
Regan, 2002), while, in non human primates masculinization of brain and behavior is 
an androgen dependent process (for a review see Wallen, 2005). Finally, recent 
studies hypothesized an important role of epigenetic changes to induce brain sexual 
differentiation (for a review see Lenz et al., 2012). 
In adult rats, AVP projections from the BST and MeA are dependent by the levels of 
circulating gonadal hormones: gonadectomy eliminates AVP expression and 
replacement of hormones reinstates it (De Vries et al., 1984a). Many AVP-ir neurons 
of BST and medial amygdala express estrogen and androgen receptors (Axelson and 
Van Leeuwen, 1990, Zhou et al., 1994). However, the activational effect of gonadal 
hormones cannot explain all differences in AVP expression because males and 
females exposed to similar steroid levels still differ (De Vries and Al Shamma, 1990, 
Wang et al., 1993), so the residual differences should be due to organizational effects 
of hormones. Similar effects have been described for almost all vertebrates (Goodson 
and Bass, 2001, Panzica et al., 2001, De Vries and Panzica, 2006). 
In rodents, the mechanism by which gonadal hormones may influence the 
differentiation of parvocellular AVP system has been studied in a variety of models. 
Neonatal treatment of male and female rats gonadectomized at postnatal day 0 (PND-
0) with either T, E2 or E2-DHT increased the number of vasopressinergic cells in the 
BST over that of DHT or oil treatment. However, treatment with DHT also 
significantly increased the number of vasopressinergic cells over that of oil treatment. 
Hence, these data confirm the role of E2 in causing sexual differentiation of the brain; 
in addition they provide a demonstration of a masculinizing effect of a 
nonaromatizable androgen on a sexually dimorphic neuropeptide system (Han and De 
Vries, 2003).  
Scordalakes and Rissman (2004) performed a study of AVP expression in Tfm, ArKO 
and ArKO-Tfm (DKO) mice. They looked the LS, the BNST and the MePD and 
found a clear sex difference only in the LS. Moreover, they found also that the Tfm 
background had no effect on AVP expression (WT and Tfm males had the greatest 
amount of AVP-ir in the LS, and displayed the most aggression in resident–intruder 
tests). These data seem in contradiction with our present results, but the study was 
performed in mice and without colchicine treatment, so there are both methodological 
and species differences.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 13 
In the same experiment Scordalakes and Rissman (2004) found in the DKO mice less 
AVP immunoreactivity as compared to the mutants lacking either ERalpha or AR, 
suggesting again a contribution of both ERalpha and AR for the differentiation of this 
system. In partial contrast with these studies, in our previous experiments using 
aromatase knock out mice (ArKO) we demonstrated that early exposure to estrogens 
is not necessary for the full differentiation of the parvocellular AVP system of BST 
and MeA. In fact, ArKO adult males do not show AVP immunoreactivity in these 
regions (Plumari et al., 2002), but, if they are exposed in adulthood to E2, AVP 
immunoreactivity is restored to levels observed in intact wild type males (Pierman et 
al., 2008). This suggests that the decrease in AVP expression in gonadally intact male 
ArKO mice was largely due to the absence of activational rather than to 
organizational effects of E2 in these mice. These results are in line with previous 
studies on alpha-fetoprotein knockout mice (AFP-KO). Indeed, AFP-KO females, not 
protected by alpha-fetoprotein, are exposed to a large amount of maternal estrogens 
during development, but they did not show a male-typical AVP system suggesting 
that, in these conditions, estrogens have probably no masculinizing effect on this 
sexually dimorphic neuropeptide system (Bakker et al., 2006). Finally, XY, XY
-Sry
, 
XX
Sry
, that are all male mice (in which Y
-
 symbolize the deletion of the gene Sry and 
Sry
 stand for the insertion of a Sry transgene) are more masculine than XX and XY
- 
female mice with regard to the density of AVP-expressing fibers in the lateral septum, 
suggesting a direct contribution of sex chromosome for the development of AVP 
sexual dimorphism (De Vries et al., 2002).  
Recent studies, performed in mice, demonstrate that ARs have a role in 
masculinization of some behaviors (Raskin et al., 2009, Juntti et al., 2010). Our data 
on Tfm rats suggest that androgens, mediated by the AR, may have an important role, 
also in the differentiation of some circuits of the rodent brain, in particular in the 
differentiation of AVP-ir elements in the parvocellular sexually dimorphic system 
located in rat BST and MeA. This effects is sex-specific, in fact, the Tfm mutation 
apparently had no effect in heterozygous carrier female, that express a wild type copy 
and a mutated copy of the AR gene and, thus, can compensate the effect with the wild 
type AR. Based on similar studies on Tfm mutants, an important role for AR to induce 
sex differences has been proposed, in rodents, also for other sexually dimorphic 
neural circuits, such as spine formation in the prefrontal cortex (Hajszan et al., 2007), 
the size of neuronal somata in the rat MeP (Morris et al., 2005) and VMHvl (Dugger 
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et al., 2007), the calbindin immunoreactivity in the mouse medial preoptic area 
(Edelmann et al., 2007), the expression of neuronal nitric oxide synthase (nNOS) in 
rat BST and medial preoptic area (Martini et al., 2008), or the astrocyte number in the 
rat medial amygdala (Johnson et al., 2008). 
The expression of mRNA for AR in the rat BST and other forebrain regions has been 
investigated by in situ hybridization, demonstrating its presence from embryonic day 
20 (ED-20). In addition, AR mRNA levels increase throughout the perinatal period. 
The developmental profile of AR mRNA in the forebrain is consistent with a 
hypothetical role for androgens acting via the AR in the organization of male typical 
neural circuits (McAbee and DonCarlos, 1998). 
Although males and females both show increases in relative AR mRNA expression 
between ED-20 and PND-10, the progression of AR mRNA levels is sex and region 
specific. On ED-20, PND-0, and PND-4, the relative expression of AR mRNA is not 
different in males and females in any of forebrain areas analyzed. Between PND-4 
and PND-10 (i.e. during the second half of the critical period for sexual 
differentiation), sex differences in AR mRNA expression arise in the BST and the 
MPOA, but not in the other analyzed regions (lateral septum, ventromedial 
hypothalamus, and arcuate nucleus). No data were provided for MeA in this study 
(McAbee and DonCarlos, 1998). These region-specific patterns in the profile of AR 
mRNA expression suggest a functional difference in the sensitivity of individual areas 
to the potential developmental actions of androgens. Experimental studies involving 
gonadectomy at PND-0 demonstrated that the onset of this sexual difference in the 
AR mRNA expression at PND-10 is due to circulating levels of T (McAbee and 
DonCarlos, 1999b), but males gonadectomized on PND-0 and treated daily with 
DHT, a nonaromatizable androgen, had low levels of AR mRNA that were not 
significantly different from AR mRNA levels in intact females. In contrast, males 
gonadectomized on PND-0 and treated daily with diethylstilbestrol (DES), a synthetic 
estrogen, maintained male-typical levels of AR mRNA in the BST and the MPOA. 
Treatment with the androgen receptor antagonist, flutamide had no effect on AR 
mRNA expression. The conclusion is that AR mRNA is up-regulated by estrogen but 
is not regulated by androgen during the early postnatal period (McAbee and 
DonCarlos, 1999a). 
In summary, available data demonstrate that AR and ER are largely present in the 
AVP system of BST/MeA, that the expression of these receptors in BST is sexually 
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differentiated from early stage of postnatal development, and that the development of 
AR mRNA differences is due to the presence of estrogens. Therefore we can 
hypothesize that both ER and AR are necessary to develop the sexual dimorphism of 
AVP parvocellular system of BST and MeA, and that their action is sequential during 
the perinatal critical period. The lack of effect of aromatase deletion (Pierman et al., 
2008) could be due to a compensatory effect of the DHT metabolite 3beta-diol that 
can stimulate the AVP promoter through ERbeta (Pak et al., 2007, 2009).  
The present analysis cannot determine whether the morphological effects of a 
defective AR are due to the protein dysfunction during the perinatal, pubertal, or adult 
period because Tfm rats have defective AR throughout development. Whether AR 
stimulation acts on the developing and/or the adult parvocellular AVP system must 
await further study. The mechanism could also involve epigenetic changes. In fact, a 
recent study demonstrated that a transient reduction in the amygdala of the expression 
of methyl-CpG-binding protein 2 (MeCP2, a protein binding to methylated DNA) 
decreased AR mRNA in two-week old males (but not in the adult), whereas it 
permanently eliminated the sex difference in the AVP system (Forbes-Lorman et al., 
2012). Thus, the reduction in AR expression during early postnatal life may play a 
role in the decrease in AVP expression in MeCP2-siRNA treated males. 
In conclusion, present data indicate that androgens, through the action of AR and in 
cooperation with estrogens, may have a relevant role in the organization and 
modulation of gender-specific components of the neural circuits that mediates male 
social behaviors, in particular the AVP producing population of BST and MeA.  
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Legends to the figures 
 
Fig.1. Schematic diagrams showing the levels and the regions (grey squares) where 
the counts were performed. Letters are referred to the different level of Bregma: a) 
0.48 for lateral septum; b) -0.26 for lateral septum; c) -0.40 for bed nucleus of the 
stria terminalis; d) -0.80 for bed nucleus of the stria terminalis; e) -2.12 for medial 
amygdaloid nucleus; f) -2.56 for medial amygdaloid nucleus. Drawings from the atlas 
of Paxinos and Watson (1998). 
 
Fig.2. Representative photomicrographs showing AVP-immunoreactive staining in 
the bed nucleus of the stria terminalis (BST) of male (XY) and female (XX) wild type 
rats as well as in Tfm rats of both sexes (X
tfm
Y and X
tfm
X). f – fornix; opt – optic tract. 
The scale bar represents 150 µm. 
 
Fig.3. Representative photomicrographs showing AVP-immunoreactive staining in 
medial amygdaloid nucleus (MeA) of male (XY) and female (XX) wild type rats as 
well as in Tfm rats of both sexes (X
tfm
Y and X
tfm
X). f – fornix; opt – optic tract. The 
scale bar represents 150 µm. 
 
Fig.4. Representative photomicrographs showing AVP-immunoreactive staining in 
the lateral septum (LS) of male (XY) and female (XX) wild type rats as well as in Tfm 
rats of both sexes (X
tfm
Y and X
tfm
X). * : third ventricle. The scale bar represents 100 
µm. 
 
Fig.5. Bar graphs illustrating the fractional area covered by AVP-ir elements 
(means+/- S.E.M.; top panel) and the cells mean (means+/- S.E.M.; bottom panel) in 
the bed nucleus of the stria terminalis (BST), medial amygdaloid nucleus (MeA), and 
lateral septum (LS), of male (XY) and female (XX) wild type rats as well as in Tfm 
rats of both sexes (X
tfm
Y and X
tfm
X). ***p<0.001, **p<0.01, *p<0.05 different from 
XY males;  
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